[HTML][HTML] Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains

H Patel, AK Hodges, C Curtis, SH Lee… - Brain, behavior, and …, 2019 - Elsevier
Individuals with intact cognition and neuropathology consistent with Alzheimer's disease
(AD) are referred to as asymptomatic AD (AsymAD). These individuals are highly likely to …

Behavioral and psychological symptoms in Alzheimer's disease

XL Li, N Hu, MS Tan, JT Yu… - BioMed research …, 2014 - Wiley Online Library
Neuropsychiatric symptoms (NPS) such as depression, apathy, aggression, and psychosis
are now recognized as core features of Alzheimer's disease (AD), and there is a general …

Concordance of clinical Alzheimer diagnosis and neuropathological features at autopsy

K Gauthreaux, TA Bonnett, LM Besser… - … of Neuropathology & …, 2020 - academic.oup.com
It remains unclear what clinical features inform the accuracy of a clinical diagnosis of
Alzheimer disease (AD). Data were obtained from the National Alzheimer's Coordinating …

Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes

D Iacono, SM Resnick, R O'Brien… - … of Neuropathology & …, 2014 - academic.oup.com
Older adults with intact cognition before death and substantial Alzheimer disease (AD)
lesions at autopsy have been termed “asymptomatic AD subjects”(ASYMAD). We previously …

A serum protein–based algorithm for the detection of Alzheimer disease

SE O'Bryant, G Xiao, R Barber, J Reisch… - Archives of …, 2010 - jamanetwork.com
Objective To develop an algorithm that separates patients with Alzheimer disease (AD) from
controls. Design Longitudinal case-control study. Setting The Texas Alzheimer's Research …

Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology

WS Liang, T Dunckley, TG Beach, A Grover… - Neurobiology of …, 2010 - Elsevier
While the clinical and neuropathological characterization of Alzheimer's Disease (AD) is well
defined, our understanding of the progression of pathologic mechanisms in AD remains …

Neurobiology of Alzheimer's disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions

J Raskin, J Cummings, J Hardy… - Current Alzheimer …, 2015 - ingentaconnect.com
Background: Alzheimer's disease (AD), the most common form of dementia, is a progressive
neurodegenerative disorder with interrelated molecular, physiological, anatomical …

Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation

JC Bis, X Jian, BW Kunkle, Y Chen… - Molecular …, 2020 - nature.com
Abstract The Alzheimer's Disease Sequencing Project (ADSP) undertook whole exome
sequencing in 5,740 late-onset Alzheimer disease (AD) cases and 5,096 cognitively normal …

[HTML][HTML] A multiomic approach to characterize the temporal sequence in Alzheimer's disease-related pathology

M Marttinen, J Paananen, A Neme, V Mitra… - Neurobiology of …, 2019 - Elsevier
No single-omic approach completely elucidates the multitude of alterations taking place in
Alzheimer's disease (AD). Here, we coupled transcriptomic and phosphoproteomic …

[HTML][HTML] Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1

QS Li, L De Muynck - Brain, Behavior, & Immunity-Health, 2021 - Elsevier
Background Alzheimer's disease (AD) is associated with abnormal tau and amyloid-β
accumulation in the brain, leading to neurofibrillary tangles, neuropil threads and …